Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Fat tissue produces a variety of secreted proteins (adipocytokines) with important roles in metabolism. We isolated a newly identified adipocytokine, visfatin, that is highly enriched in the visceral fat of both humans and mice and whose expression level in plasma increases during the development of obesity. Visfatin corresponds to a protein identified previously as pre–B cell colony-enhancing factor (PBEF), a 52-kilodalton cytokine expressed in lymphocytes. Visfatin exerted insulin-mimetic effects in cultured cells and lowered plasma glucose levels in mice. Mice heterozygous for a targeted mutation in the visfatin gene had modestly higher levels of plasma glucose relative to wild-type littermates. Surprisingly, visfatin binds to and activates the insulin receptor. Further study of visfatin's physiological role may lead to new insights into glucose homeostasis and/or new therapies for metabolic disorders such as diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Local hypoxia could also play an important role in the attraction and retention of macrophages within the adipose tissue (82) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [82]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,238
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,088
Self-citationMaeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,083
Self-citationFujioka, S., Matsuzawa, Y., Tokunaga, K., & Tarui, S. (1987) · Metabolism · doi:10.1016/0026-0495(87)90063-1 · Cited by 1,207
Self-citationLeptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038
Self-citationCloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1431 · Cited by 1,019
Research works printed but not linked: 1
- B. Samal et al., Mol. Cell. Biol.14, 1431 (1994).
Cited by
Items 201–300 of 1,001
Diabetes and inflammation: Fundamental aspects and clinical implications
Garcia, C., Feve, B., Ferré, P., Halimi, S., Baizri, H., Bordier, L., Guiu, G., Dupuy, O., Bauduceau, B., & Mayaudon, H. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.07.001 · Cited by 159
Heo, Y. J., Choi, S.-E., Jeon, J. Y., Han, S. J., Kim, D. J., Kang, Y., Lee, K. W., & Kim, H. J. (2019) · Journal of Diabetes Research · doi:10.1155/2019/4021623 · Cited by 158
“However, this report was later retracted [28]; now, IR is no longer considered to serve as a visfatin receptor.”
BackgroundPolycystic ovary syndrome, adipose tissue and metabolic syndrome
Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159
Molecular Characteristics of Serum Visfatin and Differential Detection by Immunoassays
Körner, A., Garten, A., Blüher, M., Tauscher, R., Kratzsch, J., & Kiess, W. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1304 · Cited by 159
Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance
Desai, G. S. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.730 · Cited by 157
Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians
Sandeep, S., Velmurugan, K., Deepa, R., & Mohan, V. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.005 · Cited by 158
“However, recent studies support the view that visfatin is a true adipokine that is clearly expressed in human adipocytes [7,29,30].”
BackgroundInfluentialInterleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes
Kralisch, S., Klein, J., Lossner, U., Bluher, M., Paschke, R., Stumvoll, M., & Fasshauer, M. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00090.2005 · Cited by 156
Fat poetry: a kingdom for PPARγ
Anghel, S. I., & Wahli, W. (2007) · Cell Research · doi:10.1038/cr.2007.48 · Cited by 180
New concepts in white adipose tissue physiology
de Proença, A. R. G., Sertié, R. A. L., de Oliveira, A. C., Campaãa, A. B., Caminhotto, R. D. O., Chimin, P., & Lima, F. B. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20132911 · Cited by 209
Adipokines as a link between obesity and chronic kidney disease
Briffa, J. F., McAinch, A. J., Poronnik, P., & Hryciw, D. H. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00263.2013 · Cited by 153
Visfatin Is an Adipokine, But It Is Not Regulated by Thiazolidinediones
Hammarstedt, A., Pihlajamäki, J., Sopasakis, V. R., Gogg, S., Jansson, P., Laakso, M., & Smith, U. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1395 · Cited by 168
Fain, J. N., Sacks, H. S., Buehrer, B. M., Bahouth, S. W., Garrett, E., Wolf, R. Y., Carter, R. A., Tichansky, D. S., & Madan, A. K. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803790 · Cited by 171
Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2
Kim, S.-R., Bae, S., Choi, K., Park, S.-Y., Jun, H. O., Lee, J. Y., Jang, H., Yun, I., Yoon, K., Kim, Y.-J., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.105 · Cited by 156
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2007) · Science · doi:10.1126/science.318.5850.565b · Cited by 150
Self-citationRetractedRomacho, T., Azcutia, V., Vázquez-Bella, M., Matesanz, N., Cercas, E., Nevado, J. B., Carraro, R., Rodríguez‐Mañas, L., Sánchez‐Ferrer, C. F., & Peiró, C. (2009) · Diabetologia · doi:10.1007/s00125-009-1509-2 · Cited by 150
Periodontitis and type II diabetes: a two-way relationship
Chee, B., Park, B., & Bartold, M. P. (2013) · International Journal of Evidence-Based Healthcare · doi:10.1111/1744-1609.12038 · Cited by 148
The novel adipocytokine visfatin exerts direct cardioprotective effects
Lim, S. Y., Davidson, S. M., Paramanathan, A. J., Smith, C. C. T., Yellon, D. M., & Hausenloy, D. J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00332.x · Cited by 147
The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome
Kim, J.-E., Kim, J.-S., Jo, M.-J., Cho, E., Ahn, S.-Y., Kwon, Y.-J., & Ko, G.-J. (2022) · Molecules · doi:10.3390/molecules27020334 · Cited by 145
“Obese diabetic mice were found to express more visfatin in visceral fat after weight gain [89].”
BackgroundChoi, K. C., Ryu, O. H., Lee, K. W., Kim, H. Y., Seo, J. A., Kim, S. G., Kim, N. H., Choi, D. S., Baik, S. H., & Choi, K. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.203 · Cited by 162
The ‘beneficial’ adipokines in reproduction and fertility
Campos, D. B., Palin, M., Bordignon, V., & Murphy, B. D. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803719 · Cited by 173
Impact of visceral adipose tissue on liver metabolism
Lafontan, M., & Girard, J. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.04.001 · Cited by 143
Mechanisms Linking Excess Adiposity and Carcinogenesis Promotion
Pérez-Hernández, A. I., Catalán, V., Gómez-Ambrosi, J., RodrÃguez, A., & Frühbeck, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00065 · Cited by 141
Vascular Effects of Novel Adipocytokines: Focus on Vascular Contractility and Inflammatory Responses
Yamawaki, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.307 · Cited by 142
Adipocyte, Adipose Tissue, and Infectious Disease
Desruisseaux, M. S., Nagajyothi, Trujillo, M. E., Tanowitz, H. B., & Scherer, P. E. (2007) · Infection and Immunity · doi:10.1128/iai.01455-06 · Cited by 142
Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome
Ailhaud, G. (2006) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2005.12.012 · Cited by 142
Tsochatzis, E. A., Papatheodoridis, G. V., & Archimandritis, A. J. (2009) · Mediators of Inflammation · doi:10.1155/2009/831670 · Cited by 141
Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease
Choi, K. M., Lee, J. S., Kim, E. J., Baik, S. H., Seo, H. S., Cho, Y., Oh, D. J., & Park, C. G. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0633 · Cited by 149
Social Media Scholarship and Alternative Metrics for Academic Promotion and Tenure
Cabrera, D., Roy, D., & Chisolm, M. S. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.09.012 · Cited by 144
Liu, S. W., Qiao, S. B., Yuan, J. S., & Liu, D. Q. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03453.x · Cited by 150
Getting the message across: mechanisms of physiological cross talk by adipose tissue
Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M., & Yudkin, J. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2009 · Cited by 137
Adipocytokines and hepatic fibrosis
Saxena, N. K., & Anania, F. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.01.002 · Cited by 135
Ahima, R. S., & Osei, S. Y. (2008) · Frontiers of Hormone Research · doi:10.1159/000115365 · Cited by 132
Peng, X.-D., Xie, H., Zhao, Q., Wu, X., Sun, Z., & Liao, E.-Y. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.08.012 · Cited by 143
Circulating visfatin level is correlated with inflammation, but not with insulin resistance
Oki, K., Yamane, K., Kamei, N., Nojima, H., & Kohno, N. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02966.x · Cited by 136
Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression
Moschen, A. R., Molnar, C., Wolf, A. M., Weiss, H. G., Graziadei, I. W., Kaser, S., Ebenbichler, C. F., Stadlmann, S., Moser, P. L., & Tilg, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.016 · Cited by 150
“PBEF/Nampt/visfatin has been recently characterized as a novel adipocytokine [21].”
BackgroundRole of adipocytokines in obesity-associated insulin resistance
Zou, C., & Shao, J. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.06.006 · Cited by 152
Axelsson, J., Witasp, A., Carrero, J. J., Qureshi, A. R., Suliman, M. E., Heimbürger, O., Barany, P. F., Lindholm, B., Alvestrand, A., Schalling, M., et al. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.11.021 · Cited by 141
Amato, M. C., Pizzolanti, G., Torregrossa, V., Misiano, G., Milano, S., & Giordano, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091969 · Cited by 134
Jia, W., Wu, H., Bao, Y., Wang, C., Lu, J., Zhu, J., & Xiang, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0209 · Cited by 135
Rodriguez, A., Catalan, V., Gomez-Ambrosi, J., & Fruhbeck, G. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781039599 · Cited by 133
EL-Mesallamy, H. O., Kassem, D. H., El‐Demerdash, E., & Amin, A. I. (2010) · Metabolism · doi:10.1016/j.metabol.2010.04.008 · Cited by 144
“Vaspin and visfatin/Nampt were identified as interesting insulin-sensitizing and insulinmimetic adipokines, respectively [11,13].”
BackgroundInfluentialLópez‐Mejías, R., Castañeda, S., González‐Juanatey, C., Corrales, A., Ferraz‐Amaro, I., Genre, F., Remuzgo‐Martínez, S., Rodríguez‐Rodríguez, L., Blanco, R., Llorca, J., et al. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.026 · Cited by 149
Barandiér, C., Montani, J., & Yang, Z. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01259.2004 · Cited by 146
The evolution of immune mechanisms
Danilova, N. (2006) · Journal of Experimental Zoology Part B: Molecular and Developmental Evolution · doi:10.1002/jez.b.21102 · Cited by 133
Non-alcoholic steatohepatitis and metabolic syndrome
Machado, M., & Cortez-Pinto, H. (2006) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000241677.40170.17 · Cited by 133
Conde, J., Scotece, M., Gómez, R., Lopez, V., Gómez-Reino, J. J., & Gualillo, O. (2011) · Arthritis · doi:10.1155/2011/203901 · Cited by 132
Romacho, T., Valencia, I., Ramos-González, M., Vallejo, S., López‐Esteban, M., Lorenzo, Ó., Cannata, P., Romero, A., Hipólito‐Luengo, Á. S., Gómez-Cerezo, J. F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62190-w · Cited by 146
Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis
Zhong, M., Tan, H., Gong, H., Wang, S., Zhang, Y., & Zhang, W. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03248.x · Cited by 131
Papaetis, G. S., Papakyriakou, P., & Panagiotou, T. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.52350 · Cited by 130
Essential Role of Pre–B-Cell Colony Enhancing Factor in Ventilator-induced Lung Injury
Hong, S.-B., Huang, Y., Moreno-Vinasco, L., Sammani, S., Moitra, J., Barnard, J. W., Ma, S.-F., Mirzapoiazova, T., Evenoski, C., Reeves, R. R., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1822oc · Cited by 130
Pecchi, É., Priam, S., Gosset, M., Pigenet, A., Sudre, L., Laiguillon, M.-C., Berenbaum, F., & Houard, X. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4443 · Cited by 130
Serum concentration of visfatin in obese women
Zahorska‐Markiewicz, B., Olszanecka‐Glinianowicz, M., Janowska, J., Kocełak, P., Semik-Grabarczyk, E., Holecki, M. T., Dąbrowski, P., & Skorupa, A. J. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.007 · Cited by 129
Novel Insights in the Metabolic Syndrome in Childhood and Adolescence
Bussler, S., Penke, M., Flemming, G. M. C., Elhassan, Y., Kratzsch, J., Sergeyev, E., Lipek, T., Vogel, M., Spielau, U., Körner, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479510 · Cited by 156
Physiological, pathological and potential therapeutic roles of adipokines
Falcão‐Pires, I., Castro‐Chaves, P., Miranda‐Silva, D., Lourenço, A. P., & Leite-Moreira, A. F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.04.007 · Cited by 146
Vascular biology of metabolic syndrome
Vykoukal, D., & Davies, M. G. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.01.003 · Cited by 127
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease
Yılmaz, M. İ., Sağlam, M., Carrero, J. J., Qureshi, A. R., Çağlar, K., Eyileten, T., Sönmez, A., Cakir, E., Yenicesu, M., Lindholm, B., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm727 · Cited by 128
Nicotinamide Phosphoribosyltransferase in Human Diseases
Zhang, L. Q., P. Heruth, D., & Qing Ye, S. (2011) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000038 · Cited by 126
Nicotinamide Phosphoribosyltransferase in Malignancy: A Review
Shackelford, R. E., Mayhall, K., Maxwell, N. M., Kandil, E., & Coppola, D. (2013) · Genes & Cancer · doi:10.1177/1947601913507576 · Cited by 126
Che, X.-M. (2011) · Oncology Reports · doi:10.3892/or.2011.1378 · Cited by 123
Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery
Swarbrick, M. M., Stanhope, K. L., Austrheim-Smith, I. T., Van Loan, M. D., Ali, M. R., Wolfe, B. M., & Havel, P. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1118-5 · Cited by 125
Hypoxic induction of human visfatin gene is directly mediated by hypoxia‐inducible factor‐1
Bae, S.-K., Kim, S.-R., Kim, J. G., Kim, J. Y., Koo, T. H., Jang, H.-O., Yun, I., Yoo, M.-A., & Bae, M.-K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.052 · Cited by 125
Adipokines and the Female Reproductive Tract
Reverchon, M., Ramé, C., Bertoldo, M. J., & Dupont, J. (2014) · International Journal of Endocrinology · doi:10.1155/2014/232454 · Cited by 141
Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway
Tanaka, M., 野崎, 真., Fukuhara, A., Segawa, K., Aoki, N., Matsuda, M., Komuro, R., & Shimomura, I. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.096 · Cited by 123
Self-citationThe impact of adipose tissue-derived factors on the hypothalamic-pituitary-gonadal (HPG) axis
Tsatsanis, C., Dermitzaki, E., Avgoustinaki, P. D., Malliaraki, N. E., Mytaras, V., & Margioris, A. N. (2015) · HORMONES · doi:10.14310/horm.2002.1649 · Cited by 134
Kim, M., Lee, J. H., Kim, H., Park, S.-J., Kim, S. H., Kang, G. B., Lee, Y. S., Kim, J. B., Kim, K. K., Suh, S. W., et al. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.082 · Cited by 144
Adaptation and maladaptation of the heart in obesity
Harmancey, R., Wilson, C. R., & Taegtmeyer, H. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.110031 · Cited by 121
Adipokine Gene Expression in Brain and Pituitary Gland
Wilkinson, M., Brown, R., Imran, S. A., & Ur, E. (2007) · Neuroendocrinology · doi:10.1159/000108635 · Cited by 121
Lewandowski, K. C., Stojanovic, N. D., Press, M., Tuck, S. M., Szosland, K., Bieńkiewicz, M., Vatish, M., Lewiñski, A., Prelević, G. M., & Randeva, H. S. (2007) · Diabetologia · doi:10.1007/s00125-007-0610-7 · Cited by 121
Metabolic Syndrome in Rheumatoid Arthritis
Ferraz‐Amaro, I., González‐Juanatey, C., López‐Mejías, R., Riancho‐Zarrabeitia, L., & González-Gay, M. Á. (2013) · Mediators of Inflammation · doi:10.1155/2013/710928 · Cited by 139
Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms
Ni, W., Ding, H., & Tang, L. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.017 · Cited by 121
“…stimulated the AMPK pathway to inhibit free fatty acid oxidation in the liver and skeletal muscle and decrease hepatic glucose output, while recombinant visfatin enhanced glucose uptake in 3T3-L1 adipocytes and L6 muscle cells to indirectly ameliorate insulin resistances (Fukuhara et al., 2005).”
BackgroundNeumann, E., Junker, S., Schett, G. A., Frommer, K., & Müller‐Ladner, U. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.49 · Cited by 120
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine
Grolla, A. A., Travelli, C., Genazzani, A. A., & Sethi, J. K. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13505 · Cited by 115
Hypoadiponectinemia—Cause or Consequence of Human “Insulin Resistance”?
Cook, J. R., & Semple, R. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2286 · Cited by 135
Vrachnis, N., Belitsos, P., Sifakis, S., Dafopoulos, K., Siristatidis, C., Pappa, K. I., & Iliodromiti, Z. (2012) · International Journal of Endocrinology · doi:10.1155/2012/549748 · Cited by 119
The Metabolic Syndrome as a Concept of Adipose Tissue Disease
Oda, E. (2008) · Hypertension Research · doi:10.1291/hypres.31.1283 · Cited by 131
Filippatos, T. D., Derdemezis, C. S., Kiortsis, D. N., Tselepis, A. D., & Elisaf, M. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346300 · Cited by 118
Insulin Action in Hyperthyroidism: A Focus on Muscle and Adipose Tissue
Mitrou, P., Raptis, S. A., & Dimitriadis, G. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0046 · Cited by 117
Sirtuins and Their Relevance to the Kidney
Hao, C.-M., & Haase, V. H. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010046 · Cited by 118
Sun, G., Bishop, J., Khalili, S., Vasdev, S., Gill, V. D., Pace, D., Fitzpatrick, D., Randell, E. W., Xie, Y., & Zhang, H. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.399 · Cited by 131
Adipose Tissue and Adipokines: The Association with and Application of Adipokines in Obesity
Khan, M., & Joseph, F. (2014) · Scientifica · doi:10.1155/2014/328592 · Cited by 116
Implications of exercise-induced adipo-myokines in bone metabolism
Lombardi, G., Sanchis‐Gomar, F., Perego, S., Sansoni, V., & Banfi, G. (2015) · Endocrine · doi:10.1007/s12020-015-0834-0 · Cited by 131
Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders
Dakroub, A. H., Nasser, S. A., Younis, N. K., Bhagani, H., Al-Dhaheri, Y., Pintus, G., Eid, A. A., EL‐Yazbi, A. F., & Eid, A. H. (2020) · Cells · doi:10.3390/cells9112444 · Cited by 134
“Similar to insulin, visfatin/eNAMPT exerted a glucose-lowering effect and enhanced glucose transport and lipogenesis [15].”
BackgroundInfluentialCentral Obesity as a Precursor to the Metabolic Syndrome in the AusDiab Study and Mauritius
Cameron, A. J., Boyko, E. J., Sicree, R. A., Zimmet, P. Z., Söderberg, S., Alberti, K. G. M. M., Tuomilehto, J., Chitson, P., & Shaw, J. E. (2008) · Obesity · doi:10.1038/oby.2008.412 · Cited by 116
Adipocytokine Levels in Obese and Non-obese Subjects: an Observational Study
Derosa, G., Fogari, E., D’Angelo, A., Bianchi, L., Bonaventura, A., Romano, D., & Maffioli, P. (2013) · Inflammation · doi:10.1007/s10753-013-9620-4 · Cited by 132
Lovren, F., Pan, Y., Shukla, P. C., Quan, A., Teoh, H., Szmitko, P. E., Peterson, M. D., Gupta, M., Al-Omran, M. A., & Verma, S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90780.2008 · Cited by 115
Hara, N., Yamada, K., Shibata, T., Osago, H., & Tsuchiya, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022781 · Cited by 116
Circadian Oscillation of Gene Expression in Murine Calvarial Bone
Zvonic, S., Ptitsyn, A. A., Kilroy, G. E., Wu, X., Conrad, S. A., Scott, L. K., Guilak, F., Pelled, G., Gazit, D., & Gimble, J. M. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061114 · Cited by 124
Decreased Plsma Visfatin Concentrations in Women With Gestational Diabetes Mellitus
Chan, T., Chen, Y., Lee, C., Chou, F., Wu, L.-C., Jong, S., & Tsai, E. (2006) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2006.04.007 · Cited by 115
Insights into the Link Between Obesity and Cancer
Ackerman, S. E., Blackburn, O. A., Marchildon, F., & Cohen, P. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0263-x · Cited by 132
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
Song, H. K., Lee, M., Kim, B. K., Park, Y. G., Ko, G. J., Kang, Y. S., Han, J., Han, S. Y., Han, K. H., Kim, H. K., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90231.2008 · Cited by 114
Stephens, J. M., & Vidal-Puig, A. J. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000217893.77746.4b · Cited by 113
Nampt/PBEF/Visfatin: A regulator of mammalian health and longevity?
Yang, H., Lavu, S., & Sinclair, D. A. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.003 · Cited by 120
Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases?
Neumann, E., Frommer, K. W., Vasile, M., & Müller‐Ladner, U. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30291 · Cited by 113
Effect of exercise training on plasma visfatin and eotaxin levels
Choi, K. M., Kim, J. H., Cho, G. J., Baik, S. H., Park, H. S., & Kim, S. M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0127 · Cited by 112
Why do some retracted papers continue to be cited?
Teixeira da Silva, J. A., & Bornemann-Cimenti, H. (2017) · Scientometrics · doi:10.1007/s11192-016-2178-9 · Cited by 111
Serum levels of vaspin and visfatin in patients with coronary artery disease—Kozani study
Kadoglou, N. P. E., Gkontopoulos, A., Kapelouzou, A., Fotiadis, G., Theofilogiannakos, E. K., Kottas, G., & Lampropoulos, S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.09.012 · Cited by 111
The Adipokine Visfatin is Markedly Elevated in Obese Children
Haider, D. G., Holzer, G., Schaller, G., Weghuber, D., Widhalm, K., Wagner, O., Kapiotis, S., & Wolzt, M. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000235749.50820.b3 · Cited by 111
Egr‐1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice
Yu, X., Shen, N., Zhang, M., Pan, F., Wang, C., Jia, W., Liu, C., Gao, Q., Gao, X., Xue, B., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.277 · Cited by 117
Adipose tissue changes in obesity and the impact on metabolic function
Sam, S., & Mazzone, T. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.008 · Cited by 127
Lee, W.-J., Wu, C.-S., Lin, H., Lee, I., Wu, C.-M., Tseng, J.-J., Chou, M., & Sheu, W. H. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.24 · Cited by 132
“6 Visfatin is a recently discovered visceral-fat-specific adipokine that is predominantly produced in visceral adipose tissue”
Background
Metadata
- Authors
- Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., Watanabe, E., Takagi, T., Akiyoshi, M., Ohtsubo, T., Kihara, S., Yamashita, S., Makishima, M., Funahashi, T., Yamanaka, S., Hiramatsu, R., Matsuzawa, Y., & Shimomura, I.
- Affiliations
- Japan Society for the Promotion of Science (JP)
- Department of Medicine and Pathophysiology, Graduate School of Medicine, and Department of Organismal Biosystems, Graduate School of Frontier Biosciences, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Corresponding author
- Fukuhara, Atsunori
- Matsuda, Morihiro
- Nishizawa, Masako
- Shimomura, Iichiro
- ORCID
- Venue
- Science
- Published
- 2005-01-21
- Volume
- 307
- Issue
- 5708
- Pages
- 426-430
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2135110328
- Cited by
- 1,906
- References
- 17
- Citations by year
- 2026: 10 · 2025: 24 · 2024: 45 · 2023: 55 · 2022: 62 · 2021: 53 · 2020: 52 · 2019: 76 · 2018: 93 · 2017: 71 · 2016: 82 · 2015: 122 · 2014: 117 · 2013: 128 · 2012: 107
- FWCI
- 74.12
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2007-10-26)
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- visfatin, PBEF, visceral fat, adipokines, insulin-like activity, insulin receptor, glucose homeostasis, obesity, diabetes mellitus, plasma glucose, knockout mice
- MeSH terms
- Adipose Tissue, Animals, Binding Sites, Blood Glucose, Cell Line, Cells, Cultured, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Female, Gene Expression Regulation, Humans, Insulin, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Phosphorylation, Receptor, Insulin, Recombinant Proteins, Viscera, Signal Transduction, Cytokines, Adipocytes, Gene Targeting, Molecular Mimicry, Gene Expression Profiling, Muscle Cells, Subcutaneous Tissue, Mice, Nicotinamide Phosphoribosyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.